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Exploring COVID-19 Case Fatality in Relation to the Prevalence of Chronic 
Conditions and Health Behaviors in Appalachian Kentucky 
Abstract 
Background: Research has demonstrated that common chronic conditions, especially those related to 
cardiovascular health, are important risk factors for severe COVID-19 symptoms or hospitalization. 
Population prevalence rates of such conditions have not previously been examined in relation to 
COVID-19 case fatality rates in the Central Appalachian region. 
Purpose: This study examined prevalence rates of selected chronic conditions and COVID-19 case fatality 
rates to determine whether the relationship between them is consistent across Appalachian and non-
Appalachian regions of Kentucky. 
Methods: Data from Kentucky’s Behavioral Risk Factor Survey (KyBRFS) were used to calculate 
prevalence rates of asthma, diabetes, influenza vaccination, hypertension, obesity, having a personal 
doctor, physical inactivity, and cigarette smoking. Publicly available COVID-19 case and death counts by 
county were used to calculate incidence and case fatality rates. Units of analysis were 41 single- and 
multi-county areas developed to visualize KyBRFS prevalence rates. Analysis included t-tests to compare 
Appalachian and non-Appalachian regions, and correlations characterizing associations between 
COVID-19 case fatality and rates of chronic conditions and behaviors. 
Results: Incidence and case fatality rates for COVID-19 were slightly lower in the Appalachian region, but 
not significantly. Significant correlations between COVID-19 case fatality and the prevalence of chronic 
conditions and behaviors were more common in the non-Appalachian region. 
Implications: Case fatality rates in Appalachia appear lower than expected, given the high prevalence of 
important chronic conditions and behaviors known to be associated with poor COVID-19 outcomes. This 
phenomenon merits further research and should be considered by public health researchers when 
examining COVID-19 outcomes in Kentucky and neighboring states. 
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ecent research has demonstrated that several common chronic 
conditions related to cardiovascular health—including diabetes, 
hypertension, and obesity—are important risk factors for severe COVID- 
19 symptoms or hospitalization due to COVID-19.1–4 Several of these conditions 
are also related to tobacco use, which varies widely in prevalence across the U.S. 
by geography, demography, and socioeconomic status.5,6 The Centers for Disease 
Control and Prevention (CDC) also asserts that individuals with moderate to 
severe asthma, which is associated with exposure to tobacco smoke, could be at 
greater risk for severe COVID-19.7 
 
Researchers have yet to directly examine the relationship between COVID-19 
case fatality rates and the prevalence of these chronic conditions and health- 
related behaviors in states with counties belonging to the Central Appalachian 
subregion, which includes 54 of Kentucky’s 120 counties, all of West Virginia, 
and smaller portions of Tennessee and Virginia. Although COVID-19 incidence 
has been generally lower in this region, examining case fatality is important 
because its population has very high prevalence rates of tobacco use and most 
of the chronic conditions mentioned above. Given these factors, it was 
hypothesized that COVID-19 case fatality rates would be higher in the 
Appalachian region and would be closely related to rates of chronic conditions 





Geographic patterns of COVID-19 incidence and case fatality rates were 
visualized using choropleth maps, which display quantities among regions using 
shaded colors. Prevalence rates of select chronic conditions and behaviors from 
the Kentucky Behavioral Risk Factor Survey (KyBRFS)—Kentucky’s 
implementation of the Behavioral Risk Factor Surveillance System (BRFSS) 
survey—were examined in relation to COVID-19 case fatality rate using scatter 
plots, and Pearson’s correlation coefficients. These included asthma, diabetes, 
influenza vaccination, hypertension (i.e., high blood pressure), obesity (body 
mass index>30), having a personal doctor, physical inactivity (no physical 
activity in last 30 days), and cigarette smoking (current). The BRFSS is a system 
of telephone surveys conducted by all 50 states, the District of Columbia, and 
some United States territories. Coordinated by CDC, the BRFSS provides 
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information on a great variety of health-related topics for over 400,000 
Americans annually.8 The survey has a complex sampling design and responses 
are weighted to represent known proportions of age, race and ethnicity, sex, and 
geographic region. 
 
Unfortunately, the limited number of responses to the KyBRFS survey produces 
highly unstable rates at the county level that are very likely to be inaccurate. In 
other words, there are not enough respondents in most of Kentucky’s 120 
counties to produce reliable prevalence estimates. Therefore, prevalence rates for 
16 counties with sufficient respondents to the survey, and 25 multi-county 
groups were used in this study. Counties with few respondents were aggregated 
to these multi-county groups based on similar socioeconomic and demographic 
characteristics (from the U.S. Census or American Community Survey) in a 
regionalization algorithm that required all counties in each group to be 
contiguous.9 These 41 county groups are used to report the prevalence of select 
BRFSS responses for small areas in Kentucky at the kentuckyhealthfacts.org 
website and comprised the units of analysis for this ecologic study. 
 
Because Appalachian designation is conferred by the Appalachian Regional 
Commission (ARC) to individual counties,10 it was necessary to create an 
alternative county group-level Appalachian designation to examine potential 
disparities. A county group was included in this study’s definition of the 
Appalachian region if a majority of counties comprising that county group was 
designated as Appalachian by the ARC. Where the number of ARC-defined 
Appalachian and non-Appalachian counties in a county group was equal, the 
county group was included in Appalachia if the majority of its population lived 
in ARC-defined Appalachian counties. Figure 1 displays this discrepancy 
between the ARC Appalachian designation and that used for this study. There 
were 23 non-Appalachian county groups and 18 Appalachian county groups. 
 
Combined survey data for 2017–2019 from the KyBRFS was used to calculate 
current prevalence rates of the selected chronic conditions and behaviors— 
asthma, diabetes, influenza vaccination, hypertension, obesity, having a 
personal doctor, physical inactivity, and cigarette smoking—for all 41 county 
groups, re-weighting responses and using survey weights according to CDC 
guidelines.11 Having a personal doctor was included to explore whether this basic 
indicator of healthcare accessibility from the KyBRFS might be associated with 
COVID-19 case fatality rates. Influenza vaccination was also included because 
research has shown it could be associated with lower COVID-19 mortality in 
elderly populations.12 
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County-level ARC-defined Appalachian region 





































Figure 1. Definitions of Appalachian Kentucky: Appalachian Regional Commission (ARC) 
and This Study 
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The Johns Hopkins University Center for Systems Science and Engineering 
(CSSE) online repository at GitHub.com provided cumulative COVID-19 case and 
death counts at the county level on 1 March 2021.13 These counts were 
aggregated to county groups, along with 2019 population estimates from the U.S 
Census Bureau, and incidence was calculated per 100,000 residents and 
fatalities per 100 cases (i.e., %). 
 
Open-source QGIS (version 3.10) software was used to create maps of COVID- 
19 incidence and case fatality, and Stata (version 15.1) software was used for 
statistical analysis and graphing. Statistical analysis initially consisted of 
independent sample t-tests to identify significant differences in prevalence of 
chronic conditions, and COVID-19 incidence and case fatality rates, between 
Appalachian and non-Appalachian regions of Kentucky. Independent sample t- 
tests are used to detect significant differences in the distributions of 
measurements or other values (here, COVID-19 incidence or case fatality rates) 
from two groups (here, Appalachian and non-Appalachian county groups). 
 
Stratified scatter plots were created to visualize linear relationships between the 
BRFSS variables and COVID-19 case fatality among county groups, and Pearson 
correlation coefficients were calculated to quantify these relationships and 
determine statistical significance. Correlations and fitted lines were also 
produced for all county groups. Briefly, Pearson correlation coefficients, which 
range from –1.00 to 1.00, describe the amount of variation in one quantity that 
can be predicted by variation in another, related quantity. Further, a correlation 
coefficient describes the slope of a line that best fits through the set of points in 




Table 1 displays summary statistics for each of the chronic conditions or 
behaviors, as well as COVID-19 incidence and case fatality, for Appalachian and 
non-Appalachian regions. Table 1 also indicates the number of respondents in 
each county group, showing that the means and medians for the two groups are 
fairly similar, despite differences in maximums. This table demonstrates that the 
Appalachian region had significantly higher rates of asthma, diabetes, 
hypertension, obesity, having a personal doctor, and physical inactivity. Only 
influenza vaccination and smoking were not significantly different from the non- 
Appalachian region, although smoking was marginally higher (27.7% vs. 24.4%, 
p=0.08). 
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Table 1. Chronic conditions and behaviors (BRFSS) and COVID-19 incidence and 
case fatality rates among Appalachian and non-Appalachian county groups 
 Non-Appalachian (n=23) Appalachian (n=18)  




629 628 499 278 3423 541 216 501 248 1053 0.58  
            
Current asthma 14.3 3.0 14.4 9.2 20.1 17.8 3.6 18.9 10.0 23.8 <0.01  
Diabetes* 13.4 2.6 13.9 8.2 17.9 17.4 4.5 16.8 9.5 28.6 <0.01 
Influenza 
vaccination 
39.8 3.4 40.1 32.2 45.6 39.4 5.1 39.5 30.9 49.6 0.74  
Hypertension 39.2 5.0 38.8 31.4 50.8 48.4 6.8 49.7 36.7 60.4 <0.01 
Obesity 35.3 4.1 34.2 29.1 45.7 41.3 3.3 41.5 34.6 48.0 <0.01  
Have a personal 
doctor 
81.7 3.8 81.4 72.3 89.4 85.1 3.2 84.9 80.4 90.4 <0.01 
Physical inactivity 33.1 5.0 32.4 24.6 40.2 38.9 4.4 38.1 29.1 45.9 <0.01  
Cigarette smoking 24.4 4.8 25.8 15.8 33.6 27.0 4.3 27.5 17.5 34.8 0.08 
             
COVID-19 
incidence 
8839 911 8879 7168 10,944 8797 928 8705 7552 10,493 0.89 
COVID-19 case 
fatality* 
1.26 0.53 1.20 0.61 2.81 1.14 0.40 1.18 0.43 1.97 0.58  
 
 
The incidence and case fatality rates for COVID-19 were quite similar among 
Appalachian and non-Appalachian regions (p=0.89 and p=0.58, respectively). 
Figures 2a and 2b display maps of COVID-19 incidence and case fatality by 
county group that enable visualization of these differences. Several single-county 
“county groups” with high incidence rates are discernible across the state in 
Figure 2a. There were more county groups in the Appalachian region with high 
incidence of COVID-19, but high and low rates were scattered throughout the 
state. Figure 2b shows that many county groups with the highest case fatality 
rates were in western Kentucky, including several along the southern border 
with Tennessee, while case fatality rates in the Appalachian region generally 
appeared similar to those in central and northern Kentucky. 
 
Scatter plots showing the relationships between COVID-19 case fatality and the 
selected conditions and behaviors appear in Figure 3 (COVID-19 case fatality 
rates and prevalence of chronic conditions and behaviors by county group in 
Appalachian and non-Appalachian regions. These plots (specifically, the gray 
fitted lines), and the accompanying correlation statistics, demonstrate that there 
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Case fatality rate (%) 
0.43 - 0.78 
0.78 - 1.09 
1.09 - 1.30 
1.30 - 1.47 
















Figure 2b. COVID-19 Case Fatality by County Group 
Study-defined Appalachian region 
 
Cases per 100,000 
7168 - 7945 
7945 - 8675 
8675 - 8891 
8891 - 9569 
9569 - 10,944 
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were few significant relationships when all county groups were analyzed 
together. Note that most of the gray fitted lines are relatively flat—indicating very 
little correlation—compared to the blue and red lines. When non-Appalachian 
and Appalachian county groups were analyzed separately, relationships became 
quite apparent, especially among non-Appalachian county groups, which had 
steeper slopes for the fitted lines. In almost every graph, combined analysis 
produced smaller correlation coefficients and larger p-values when compared to 
non-Appalachian analysis. There were notable and statistically significant 
correlations between all chronic conditions related to the cardiovascular system 
and case fatality rates in the non-Appalachian region. Furthermore, prevalence 
rates of physical inactivity were significantly correlated with COVID-19 case 
fatality in the Appalachian region after stratification. 
 
Regardless of stratification, there were no significant correlations observed 
between COVID-19 case fatality and prevalence rates of asthma, having a 
personal doctor, or cigarette smoking, although the last of these was nearly 
significant (r=0.30, p=0.06). 
 
IMPLICATIONS 
Case fatality rates due to COVID-19 are not evenly distributed across the state. 
This study found that variation in cardiovascular health across regions of 
Kentucky could explain some of this difference. One of the most important 
findings of our analysis was that COVID-19 case fatality rates were not higher in 
the Appalachian region compared to the rest of the state. This was somewhat 
unexpected, given the high rates of conditions and behaviors known to increase 
risk for severe disease, and merits further investigation. 
 
Analysis initially showed few significant relationships between prevalence rates 
of cardiovascular conditions and COVID-19 case fatality, but stratification by 
region demonstrated several substantial and statistically significant correlations 
in the non-Appalachian region. Furthermore, some correlations for the 
Appalachian region trended toward the expected direction, and the correlation 
with physical inactivity was stronger and significant. Still, there was little 
association between COVID-19 case fatality and the other chronic conditions in 
Appalachia when compared to the rest of the state. 
 
It is unclear why some relationships that clearly manifested in the non- 
Appalachian region were not observed in Appalachia. It is possible that there are 
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Cigarette smoking prevalence (%) 
 
Figure 3. COVID-19 case fatality rates and prevalence of chronic conditions 
and behaviors by county group in Appalachian and non-Appalachian regions. 
 
All county groups: r=0.30, p=0.06 
Appalachian: r=0.37, p=0.13 
Non-Appalachian: r=0.35, p=0.11 
 
All county groups: r=0.39, p=0.01 
Appalachian: r=0.43, p=0.07 
Non-Appalachian: r=0.81, p<0.01 
 
All county groups: r=0.48, p<0.01 
Appalachian: r=0.71, p<0.01 
Non-Appalachian: r=0.63, p<0.01 
 
All county groups: r=-0.37, p=0.02 
Appalachian: r=-0.31, p=0.20 
Non-Appalachian: r=-0.47, p=0.02 
 
All county groups: r=-0.12, p=0.46 
Appalachian: r=0.30, p=0.22 
Non-Appalachian: r=-0.25, p=0.25 
 
All county groups: r=0.22, p=0.17 
Appalachian: r=0.23, p=0.37 
Non-Appalachian: r=0.50, p=0.02 
 
All county groups: r=0.25, p=0.12 
Appalachian: r=0.25, p=0.32 
Non-Appalachian: r=0.52, p=0.01 
 
All county groups: r=0.03, p=0.83 
Appalachian: r=-0.15, p=0.56 






















































































































































































































































Journal of Appalachian Health, Vol. 3 [2021], Iss. 2, Art. 5
https://uknowledge.uky.edu/jah/vol3/iss2/5
DOI: https://doi.org/10.13023/jah.0302.05
important determinants of COVID-19 case fatality that are simply more or less 
prevalent in Appalachia, but not considered here. Proximity to Tennessee, which 
has had higher incidence and case fatality rates due to COVID-19, or to West 
Virginia, where incidence has been lower, might explain some regional 
differences observed in Kentucky.14 Another possibility is simply that the 
number of analytical units for the Appalachian region (n=18 county groups) is 
too few to provide reliable accuracy. It is notable, however, that a first draft of 
this article considered substantially fewer weeks of data on COVID-19 cases and 
deaths (analysis not shown), and the updated analysis shown here resulted in 
no major differences to interpretation. 
 
In most cases, higher correlation coefficients were observed in both regions 
separately than when analyzed together, regardless of statistical significance. 
This is partially due to generally higher rates of the BRFSS conditions and 
behaviors in the Appalachian region, as observed in Table 1 and Figure 4. Note 
in all scatter plots that the Appalachian points are distributed among higher 
values on the x-axis, even though the fitted line can be similar, if less steep. This 
is why the fitted line appears flatter when both regions are analyzed together— 
the Appalachian values extend the overall point pattern farther into the lower- 
right quadrant of the graph, thereby obscuring the positive correlations in each 
region. This is most evident in the scatter plot for physical inactivity, where the 
correlation coefficients—and fitted line slopes—for each region, are similar, but 
Appalachia is shifted to the right due to generally higher rates of physical 
inactivity in that region. Future public health researchers should carefully 
consider the Appalachian region in epidemiologic analysis of COVID-19 
outcomes relative to cardiovascular conditions or risk factors. Failure to stratify 
by—or adjust for—the Appalachian region in could bias toward null findings in 
population-level analyses such as this one. It is important to note, however, that 
the findings of this study also indicate the Appalachian region may have less 
relevance for this pandemic than other public health matters, such as cancer, 
diabetes, and heart disease. 
 
This study is limited in some ways that merit careful consideration. First, using 
cumulative case and death counts to estimate case fatality is not optimal until 
an outbreak has concluded, which is certainly not the case for the COVID-19 
pandemic as of this writing. A better estimate of case fatality would have used 
the sum of deaths and recovered individuals as the denominator but counts of 
recovered individuals were not available at the county level in the data set 
accessed for this study. It seems unlikely, however, that this issue would explain 
the notable differences that were observed between Appalachian and non- 
Appalachian regions. 
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SUMMARY BOX 
What is already known about this topic? Chronic cardiovascular conditions 
are known to be associated with risk of severe COVID-19 symptoms or death. 
 
What is added by this report? This report shows that COVID-19 case fatality 
rates are relatively low in Appalachian Kentucky, despite high prevalence of 
such conditions in the local population. 
 
What are the implications for future research? The Appalachian region does 
not necessarily have high COVID-19 case fatality rates but may need to be 
considered separately in analysis of population health. 
The definition of the Appalachian region proposed by this work is also somewhat 
limiting in that it does not conform to the county-level designations from the 
ARC. Alternative analyses that included both additional and fewer county groups 
designated as Appalachian produced very similar results (analysis not shown), 
however, indicating that this study’s results are relatively robust to small 
changes in the Appalachian classification. 
 
This analysis noted slightly lower but very similar COVID-19 case fatality in 
Appalachian Kentucky compared to the rest of the state, at least through 
February 28, 2021. Further, case fatality in the region was not as closely 
associated with important measures of population health as outside the region. 
The findings of this study are largely consistent with much of the recent research 
describing cardiovascular conditions and related behaviors as important risk 
factors for severe COVID-19 disease. There are, however, important differences 
between Appalachian and non-Appalachian regions which merit further research 
and should be considered when examining COVID-19 outcomes in Kentucky and 
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